{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:46:22Z","timestamp":1792039582899,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hlc.2026.05.016","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:06:04Z","timestamp":1792037164000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein(a) Reporting by Australian Chemical Pathology Laboratories"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-4102","authenticated-orcid":false,"given":"Jeff R.","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2772-0695","authenticated-orcid":false,"given":"Sean","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-1524","authenticated-orcid":false,"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-7314","authenticated-orcid":false,"given":"Nick S.R.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0790-5118","authenticated-orcid":false,"given":"Robert","family":"Hungerford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0222-5468","authenticated-orcid":false,"given":"Peter J.","family":"Psaltis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-2548","authenticated-orcid":false,"given":"Adam J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2026.05.016_bib1","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.hlc.2026.05.016_bib2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.05.016_bib3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.hlc.2026.05.016_bib4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2026.05.016_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/heartjnl-2021-320708","article-title":"Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target","volume":"109","author":"Di Fusco","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2026.05.016_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.hlc.2026.05.016_bib7","article-title":"Lp(a) testing and LDL-C levels among Australian ASCVD patients in 2022: a cross-sectional study from the Advara HeartCare Network (PREVAIL)","volume":"45","author":"Eccleston","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.05.016_bib8","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1093\/eurjpc\/zwae155","article-title":"Trends and disparities in lipoprotein(a) testing in a large integrated US health system, 2000\u201323","volume":"31","author":"Faaborg-Andersen","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hlc.2026.05.016_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031255","article-title":"Lipoprotein(a) testing trends in a Large Academic Health System in The United States","volume":"12","author":"Bhatia","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2026.05.016_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100478","article-title":"Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes","volume":"14","author":"Kelsey","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.hlc.2026.05.016_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120447","article-title":"Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis","volume":"409","author":"Morton","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2026.05.016_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.33963\/v.phj.106327","article-title":"Current perspectives on Lp(a)-lowering therapies: who may benefit?","volume":"83","author":"Nicholls","year":"2025","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.hlc.2026.05.016_bib13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2003.023689","article-title":"Report of the National Heart, Lung, and Blood Institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions","volume":"49","author":"Marcovina","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.hlc.2026.05.016_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2019.10.011","article-title":"HEART UK consensus statement on lipoprotein(a): A call to action","volume":"291","author":"Cegla","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2026.05.016_bib15","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2026.05.016_bib16","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): A genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.hlc.2026.05.016_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.hlc.2022.11.015","article-title":"Australian Atherosclerosis Society position statement on lipoprotein(a): clinical and implementation recommendations","volume":"32","author":"Ward","year":"2023","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.05.016_bib18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/jalm\/jfae057","article-title":"ADLM guidance document on the measurement and reporting of lipids and lipoproteins","volume":"9","author":"Cao","year":"2024","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.hlc.2026.05.016_bib19","series-title":"Lipoprotein(a) testing as an independent predictor of cardiovascular disease","year":"1736"},{"key":"10.1016\/j.hlc.2026.05.016_bib20","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.hlc.2026.05.016_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/00045632231210682","article-title":"The current status of lipoprotein (a) measurement in clinical biochemistry laboratories in the UK: results of a 2021 national survey","volume":"61","author":"Ansari","year":"2024","journal-title":"Ann Clin Biochem"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626004257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626004257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:06:06Z","timestamp":1792037166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950626004257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"alternative-id":["S1443950626004257"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.05.016","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) Reporting by Australian Chemical Pathology Laboratories","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}